PK/PD Modeling of Magnesium in the Mother and Neonate
NCT01709630 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 151
Last updated 2014-11-20
Summary
Determine significant correlations between maternal serum magnesium levels, and maternal and neonatal outcomes.
Conditions
- Magnesium Sulfate Pharmacokinetics and Pharmacodynamics
Interventions
- DRUG
-
Magnesium sulfate infusion
Participants will be given magnesium sulfate infusion as part of their normal care for either preeclampsia, tocolysis, or neuroprotection.
Sponsors & Collaborators
- lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2014-10-31
- Completion
- 2014-10-31
Countries
- United States
Study Locations
More Related Trials
-
Magnesium Sulfate in Obese Preeclamptics
NCT02835339 ·Status: COMPLETED ·Phase: PHASE4
-
Development of Pharmacokinetics Model in Pregnancy Women and Fetus
NCT01916330 ·Status: COMPLETED
-
Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia
NCT00004399 ·Status: COMPLETED ·Phase: NA
-
The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat
NCT05520021 ·Status: UNKNOWN ·Phase: NA
-
Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study
NCT05535660 ·Status: COMPLETED
-
Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling of Ampicillin and Gentamicin in Peripartum Patients
NCT02427932 ·Status: COMPLETED
-
Protocols for Magnesium Sulfate Maintenance Dose in Overweight and Obese Women Diagnosed With Preeclampsia
NCT06486025 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection
NCT02506894 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
NCT00014989 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Magnesium on Maternal Mood, Cognitive Function, and Birth Experience
NCT02454322 ·Status: COMPLETED
-
Treatment of Persistent Pulmonary Hypertension in Neonates With Nebulized Magnesium Sulfate
NCT06603766 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Impact of Body Mass Index on Serum Maternal and Fetal Magnesium Level
NCT03928691 ·Status: UNKNOWN
-
Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach
NCT02164370 ·Status: COMPLETED
-
Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa
NCT03542552 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Satisfaction With Abbreviated Postpartum Magnesium Sulfate for Severe Preeclampsia
NCT05789381 ·Status: WITHDRAWN ·Phase: NA
-
New Magnesium Sulphate Protocol for Pre-eclampsia
NCT01846156 ·Status: COMPLETED ·Phase: PHASE3
-
Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled Trial
NCT03318211 ·Status: UNKNOWN ·Phase: PHASE4
-
Regulation Of Maternal Fuel Supply And Neonatal Adiposity
NCT00826904 ·Status: COMPLETED
-
Serum Magnesium Level Administration in Severe Pre-eclampsia Obese Pregnancy
NCT03661775 ·Status: COMPLETED ·Phase: NA
-
Effect of Administering Intravenous Magnesium Sulfate on Fetal Cardiotocography and Neonatal Outcome in Preeclamptic Patients
NCT03237000 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of 1 g Vs 2 g Per Hour Intravenous Maintenance Dose of MgSO4 in Women With Severe Pre-eclampsia
NCT03164304 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Magnesium Sulphate on the Intracranial Pressure of Preeclamptic Patients
NCT03210350 ·Status: COMPLETED
-
Placental Passage and Disposition of Drugs: A Physiology-based Approach
NCT02438631 ·Status: RECRUITING
-
Maternal Dietary Lipids and Omega 3 Essential Fatty Acids Profile in Pregnant Women at Term and Their Fetuses
NCT02925013 ·Status: COMPLETED ·Phase: NA
-
Effectiveness Study of Short Course of Magnesium Sulfate for Severe Preeclamsia
NCT01408979 ·Status: COMPLETED ·Phase: PHASE4